Angiogenesis inhibitors for lung cancer: Clinical developments and future directions

George Blumenschein; John V. Heymach

doi:10.1016/S1556-0864(15)30398-1

Angiogenesis inhibitors for lung cancer: Clinical developments and future directions

George Blumenschein, John V. Heymach

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	744-748
Number of pages	5
Journal	Journal of Thoracic Oncology
Volume	1
Issue number	7
DOIs	https://doi.org/10.1016/S1556-0864(15)30398-1
State	Published - Sep 2006

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.1016/S1556-0864(15)30398-1

Cite this

@article{d8b0929923194ccab6579393c1af449b,

title = "Angiogenesis inhibitors for lung cancer: Clinical developments and future directions",

author = "George Blumenschein and Heymach, {John V.}",

year = "2006",

month = sep,

doi = "10.1016/S1556-0864(15)30398-1",

language = "English (US)",

volume = "1",

pages = "744--748",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "7",

}

TY - JOUR

T1 - Angiogenesis inhibitors for lung cancer

T2 - Clinical developments and future directions

AU - Blumenschein, George

AU - Heymach, John V.

PY - 2006/9

Y1 - 2006/9

UR - http://www.scopus.com/inward/record.url?scp=34247895659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247895659&partnerID=8YFLogxK

U2 - 10.1016/S1556-0864(15)30398-1

DO - 10.1016/S1556-0864(15)30398-1

M3 - Article

C2 - 17409952

AN - SCOPUS:34247895659

SN - 1556-0864

VL - 1

SP - 744

EP - 748

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 7

ER -

Angiogenesis inhibitors for lung cancer: Clinical developments and future directions

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this